Accuracy and Safety of the Syai Tag System for Continuous Glucose Monitoring in Intensive Internal Care Unit

Recruiting N/A Interventional Study
Diabetes Mellitus Blood Sugar Sepsis Critically Ill Intensive Care Unit Patients
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Device Feasibility
Participants needed
100 (estimated)
Sponsor
University Medical Centre Maribor · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Researchers at the Department of Intensive Internal Medicine and the Department of Endocrinology and Diabetology will conduct a study to verify the accuracy and safety of the new Syai Tag system for continuous glucose monitoring in patients in intensive internal care. Almost 150,000 people in Slovenia have diabetes, so keeping a close eye on blood sugar levels is key to preventing complications. T…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Admission to the intensive care unit * Expected ICU stay more than 24 hours * Presence of an arterial line Exclusion Criteria: * Age under 18 * Pregnancy * Skin changes that prevent sensor application
Contacts

Nika Kravos Tramšek, MD PhD

+38631423030

nikakravos@gmail.com

CONTACT